144 related articles for article (PubMed ID: 32887729)
1. Administration of label and off-label drugs by the subcutaneous route in palliative care: an observational cohort study.
Jensen JJ; Sjøgren P
BMJ Support Palliat Care; 2022 Dec; 12(e6):e723-e729. PubMed ID: 32887729
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous Drugs and Off-label Use in Hospice and Palliative Care: A Scoping Review.
Wernli U; Dürr F; Jean-Petit-Matile S; Kobleder A; Meyer-Massetti C
J Pain Symptom Manage; 2022 Nov; 64(5):e250-e259. PubMed ID: 35870656
[TBL] [Abstract][Full Text] [Related]
3. Off-label drugs in palliative care: a Group Delphi treatment recommendation process.
Remi C; Weingärtner K; Hagemann V; Bausewein C; Hodiamont F
BMJ Support Palliat Care; 2021 Jun; 11(2):180-187. PubMed ID: 32398226
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Subcutaneous Phenobarbital Administration in Hospice Patients.
Hosgood JR; Kimbrel JM; McCrate Protus B; Grauer PA
Am J Hosp Palliat Care; 2016 Apr; 33(3):209-13. PubMed ID: 25473092
[TBL] [Abstract][Full Text] [Related]
5. [Off-label use in palliative medicine].
Rémi C; Gerlach C
Schmerz; 2021 Feb; 35(1):61-73. PubMed ID: 33443680
[TBL] [Abstract][Full Text] [Related]
6. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol.
Nguyen KA; Mimouni Y; Jaberi E; Paret N; Boussaha I; Vial T; Jacqz-Aigrain E; Alberti C; Guittard L; Remontet L; Roche L; Bossard N; Kassai B
Therapie; 2021; 76(6):675-685. PubMed ID: 33593598
[TBL] [Abstract][Full Text] [Related]
7. Off-label prescriptions in Italian hospices: a national survey.
Toscani F; Di Giulio P; Campi R; Pellerin I; De Luca A; Casale G;
J Pain Symptom Manage; 2009 Sep; 38(3):365-71. PubMed ID: 19564095
[TBL] [Abstract][Full Text] [Related]
8. Off-label use in adult palliative care - more common than expected. A retrospective chart review.
Hagemann V; Bausewein C; Remi C
Eur J Hosp Pharm; 2022 Nov; 29(6):329-335. PubMed ID: 36283723
[TBL] [Abstract][Full Text] [Related]
9. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
[TBL] [Abstract][Full Text] [Related]
10. Off-Label and Unlicensed Drugs in Pediatric Palliative Care: A Prospective Observational Study.
García-López I; Cuervas-Mons Vendrell M; Martín Romero I; de Noriega I; Benedí González J; Martino-Alba R
J Pain Symptom Manage; 2020 Nov; 60(5):923-932. PubMed ID: 32569831
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.
Turner S; Nunn AJ; Fielding K; Choonara I
Acta Paediatr; 1999 Sep; 88(9):965-8. PubMed ID: 10519338
[TBL] [Abstract][Full Text] [Related]
12. Drug use beyond the licence in palliative care: A systematic review and narrative synthesis.
Hagemann V; Bausewein C; Remi C
Palliat Med; 2019 Jun; 33(6):650-662. PubMed ID: 31017533
[TBL] [Abstract][Full Text] [Related]
13. Off-label use of psychotropic drugs in a Swiss paediatric service: similar results from two different cohort studies.
Feka A; Di Paolo ER; Pauchard JY; Mariguesa A; Gehri M; Sadeghipour F
Swiss Med Wkly; 2022 Jan; 152():w30124. PubMed ID: 35147399
[TBL] [Abstract][Full Text] [Related]
14. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions.
Aagaard L; Hansen EH
Br J Clin Pharmacol; 2011 May; 71(5):751-7. PubMed ID: 21241353
[TBL] [Abstract][Full Text] [Related]
15. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
Saiyed MM; Lalwani T; Rana D
Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
[TBL] [Abstract][Full Text] [Related]
16. Safe Use of Subcutaneous Diphenhydramine in the Inpatient Hospice Unit.
Chen A; Loquias EJ; Roshan R; Levene R; Zelhof R; Hickey T; Cooney GA; Gonzalez F
Am J Hosp Palliat Care; 2017 Dec; 34(10):954-957. PubMed ID: 27625354
[TBL] [Abstract][Full Text] [Related]
17. Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review.
Oshikoya KA; Wharton GT; Avant D; Van Driest SL; Fenn NE; Lardieri A; Doe E; Sood BG; Taketomo C; Lieu P; Yen L; McMahon AW
Paediatr Drugs; 2019 Feb; 21(1):47-58. PubMed ID: 30484072
[TBL] [Abstract][Full Text] [Related]
18. Pediatric Palliative Care at Home: A Prospective Study on Subcutaneous Drug Administration.
García-López I; Chocarro-González L; Martín-Romero I; Vázquez-Sánchez JM; Avilés-Martínez M; Martino-Alba R
J Pain Symptom Manage; 2023 Sep; 66(3):e319-e326. PubMed ID: 37244525
[TBL] [Abstract][Full Text] [Related]
19. Palliative care organization and staffing models in residential hospices: Which makes the difference?
Artico M; Piredda M; D'Angelo D; Di Nitto M; Giannarelli D; Marchetti A; Facchinetti G; De Chirico C; De Marinis MG
Int J Nurs Stud; 2022 Feb; 126():104135. PubMed ID: 34923319
[TBL] [Abstract][Full Text] [Related]
20. Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.
Eguale T; Buckeridge DL; Verma A; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
JAMA Intern Med; 2016 Jan; 176(1):55-63. PubMed ID: 26523731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
